Center-Authored Papers

Filters: Author is Hoque, Ashraful  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
TESTOSTERONE
Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ et al..  2011.  Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Carcinogenesis. 32(10):1500-1506. Abstract
Shared Resources
Neuhouser ML, Till C, Kristal AR, Goodman P, Hoque A, Platz EA, Hsing AW, Albanes D, Parnes HL, Pollak M.  2010.  Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Cancer prevention research (Philadelphia, Pa.). 3(3):279-89. Abstract
September 2011
Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ et al..  2011.  Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Carcinogenesis. 32(10):1500-1506. Abstract
Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JKV, Tang L et al..  2011.  Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.. Cancer causes & control : CCC. 22(8):1121-31. Abstract
Risk Factors
Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ et al..  2011.  Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Carcinogenesis. 32(10):1500-1506. Abstract
Neuhouser ML, Till C, Kristal AR, Goodman P, Hoque A, Platz EA, Hsing AW, Albanes D, Parnes HL, Pollak M.  2010.  Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Cancer prevention research (Philadelphia, Pa.). 3(3):279-89. Abstract
Price DK, Chau CH, Till C, Goodman PJ, Baum CE, Ockers SB, English BC, Minasian L, Parnes HL, Hsing AW et al..  2010.  Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.. The Journal of urology. 184(6):2297-302. Abstract
Hoque A, Ambrosone CB, Till C, Goodman PJ, Tangen CM, Kristal AR, Lucia S, Wang Q, Kappil M, Thompson I et al..  2010.  Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial.. Cancer prevention research (Philadelphia, Pa.). 3(4):478-83. Abstract
Risk Assessment
Hoque A, Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JKV et al..  2015.  Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease.. Urology. 85(3):616-20. Abstract
Research Design
Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia SM, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML et al..  2010.  Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.. Cancer prevention research (Philadelphia, Pa.). 3(12):1523-33. Abstract
Research
Platz EA, Sutcliffe S, De Marzo AM, Drake CG, Rifai N, Hsing AW, Hoque A, Neuhouser ML, Goodman PJ, Kristal AR.  2010.  Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies.. Cancer causes & control : CCC. 21(6):847-51. Abstract
Repetitive Sequences, Nucleic Acid
Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ et al..  2011.  Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Carcinogenesis. 32(10):1500-1506. Abstract
Receptors, Androgen
Price DK, Chau CH, Till C, Goodman PJ, Baum CE, Ockers SB, English BC, Minasian L, Parnes HL, Hsing AW et al..  2010.  Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.. The Journal of urology. 184(6):2297-302. Abstract
Randomized Controlled Trials as Topic
Price DK, Chau CH, Till C, Goodman PJ, Baum CE, Ockers SB, English BC, Minasian L, Parnes HL, Hsing AW et al..  2010.  Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.. The Journal of urology. 184(6):2297-302. Abstract
Radioimmunoassay
Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ et al..  2011.  Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Carcinogenesis. 32(10):1500-1506. Abstract
Public Health Sciences Division
Price DK, Chau CH, Till C, Goodman PJ, Baum CE, Ockers SB, English BC, Minasian L, Parnes HL, Hsing AW et al..  2010.  Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.. The Journal of urology. 184(6):2297-302. Abstract
Hoque A, Ambrosone CB, Till C, Goodman PJ, Tangen CM, Kristal AR, Lucia S, Wang Q, Kappil M, Thompson I et al..  2010.  Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial.. Cancer prevention research (Philadelphia, Pa.). 3(4):478-83. Abstract
Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia SM, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML et al..  2010.  Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.. Cancer prevention research (Philadelphia, Pa.). 3(12):1523-33. Abstract
Neuhouser ML, Platz EA, Till C, Tangen CM, Goodman PJ, Kristal A, Parnes HL, Tao Y, Figg WD, Lucia SM et al..  2013.  Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.. Cancer prevention research (Philadelphia, Pa.). 6(2):91-9. Abstract
Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ et al..  2011.  Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Carcinogenesis. 32(10):1500-1506. Abstract
Platz EA, Sutcliffe S, De Marzo AM, Drake CG, Rifai N, Hsing AW, Hoque A, Neuhouser ML, Goodman PJ, Kristal AR.  2010.  Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies.. Cancer causes & control : CCC. 21(6):847-51. Abstract
Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JKV, Tang L et al..  2011.  Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.. Cancer causes & control : CCC. 22(8):1121-31. Abstract
Neuhouser ML, Till C, Kristal AR, Goodman P, Hoque A, Platz EA, Hsing AW, Albanes D, Parnes HL, Pollak M.  2010.  Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Cancer prevention research (Philadelphia, Pa.). 3(3):279-89. Abstract
Kristal AR, Till C, Tangen CM, Goodman PJ, Neuhouser ML, Stanczyk FZ, Chu LW, Patel SK, Thompson IM, Reichardt JK et al..  2012.  Associations of Serum Sex Steroid Hormone and 5α-Androstane-3α,17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Gurel B, Lucia SM, Thompson IM, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S et al..  2014.  Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract